Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

50.0%

-36.5% vs benchmark

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

3Total
P 3 (1)
P 4 (2)

Trial Status

Recruiting2
Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Activity Timeline